🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#spatialbiology fans, join us at the Oxford global Spatial Biology US 2023 in Boston on June 8th and 9th, where Navinci proudly serves as a Silver Sponsor! Don't miss the opportunity to meet our exceptional team! #OmicsSeries23 #SpatialResearch #SpatialTechnologies

Join us at the EACR in Torino, Italy! Mark your calendars for June 12-15 as Navinci unveils its highly anticipated PD1/PD-L1 product at the #EACR23 congress. We invite you to visit us at booth 79 in the exhibition hall, where we will showcase our latest advancements.

Illuminate PD1/PD-L1 Interactions! Today is the #launch of our in situ assay for the detection of PD1/PD-L1 interactions. Fluorescent readout + multiplex co-staining = gain comprehensive visualization of the tumor microenvironment. #cancerresearch #spatialbiology

Second day of #EACR2023 is here! Meet our team and celebrate the #launch of our new PD1/PD-L1 interaction assay! Learn how to visualize protein protein interaction and costaining! Read more: navinci.se/pd1-signaling/ #Immunotherapy #CancerResearch #EACR23

#EACR2023 is in full swing! Today, Eva presents poster: "Multiplexed proximity ligation-based method uncovers immune checkpoint activation in the context of the tumor microenvironment" in #immunotherapy (topic #Immunecheckpoints). Digital copy here: navinci.se/eacr2023/

Interested in PD1/PD-L1 interaction detection? PDL1 is a commonly used biomarker, but its correlation with immunotherapy outcomes isn’t always linear. Navinci's new PD1/PD-L1 Atto647N kit solves this challenge. 1/2

Navinci sells very good products for in situ PLA! We use it in the lab and we are happy. Moreover, they are fully supportive always and available to help and sort out what is going wrong.

🔬🧬 Dive into the world of Tertiary Lymphoid Structures! 🌟 Join us at IFOM Milan on Sept 19th for an enlightening meeting on TLS. Under the auspices of Fondazione AIRC per la ricerca sul cancro and with the contribution of Navinci Subscribe now: secure.onlinecongress.it/onlinecongress…

It's a beautiful day & we are looking forward to welcoming everyone to the Manchester Breast Centre (MBC) Symposium Manchester Cancer Research Centre with lots of great talks & posters on the agenda. Thank you to our sponsors Breast Cancer Now, Proteintech Group, Navinci & Agilent Division of Cancer Sciences #MBC2024

Last week, we joined forces with Leica Biosystems for a webinar on how to use Navinci's in situ proximity ligation assay automated on Leica's BOND RX/RXm automated stainer - watch the on demand recording here: labroots.com/ms/webinar/thr… Labroots

New Publication Alert! We are excited to announce our recent efforts published in Nature BME focusing on "spatial interactomics" a new trend in spatial omics to go beyond "localizing proteins" only using multiplexed imaging or sequencing rdcu.be/dYzK3 Coulter BME | Emory & Georgia Tech

Navinci are proud to be exhibiting at the Society for Immunotherapy of Cancer Annual Meeting 2024 in Houston Find us at booth #834, at one of our six poster presentations, or book a meeting with us! Find out more and book a meeting here: navinci.se/events/sitc-20…

New fully automated in situ proximity ligation assay kits for the BOND RX/RXm Fully Automated Research Stainer, in partnership with Leica Biosystems - now available with fluorescent readout. Visit us at Society for Immunotherapy of Cancer booth #834 to learn more! 🔗 Read more: navinci.se/new-kits-for-l…

Thrilled to share a Spatial Interaction study from the lab - Spatial interaction mapping of PD-1/PD-L1 in Head and Neck Cancer reveals the role of Macrophage-Tumour Barriers associated with immunotherapy response UQ Medicine Majid Ebrahimi Warkiani Navinci researchsquare.com/article/rs-539…

Excited to share a collaboration with Arutha K UQ Medicine and Akoya Biosciences, ‘Spatial interaction mapping of PD-1/PD-L1 in Head and Neck Cancer reveals the role of Macrophage-Tumour Barriers associated with immunotherapy response’ Read the pre-print here: lnkd.in/en3Pdr5X

New publication🧠 In the Greenamyre lab at Pitt Health Sciences, they study Parkinson’s disease and use Navinci’s isPLA assay regularly to decipher novel mechanisms that contribute to the disease. Read their latest paper: lnkd.in/dZnaR8Hn Matt Keeney Science Magazine

💥Final #Multiomics2024 session for Day 1/3. What a stellar lineup to end the day on! We heard amazing talks from Mainthan Palendira (Mainthan Palendira), Martin Smith (Martin Smith), Gabrielle Belz (@ProfGabBelz), Joanna Kowal (Joanna Kowal), & Subham Basu (Navinci).

Subham Basu Navinci #multiomics2024